Agree somewhat, but its moreso expanding the market rather strategy change. I'm sure DT would say they don't have the bandwidth though, unless they want us to be diluted ....
Personally, I'd love to see more trials with other synergistic drug classes outside anthracyclines (dox) so there's something enticing for a range of different BP pipelines. Seems like you'd want them all getting concurrent readouts to get a bidding war happening
Agree somewhat, but its moreso expanding the market rather...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
-0.015(0.91%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.66 | $1.64 | $54.86K | 33.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17732 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 2600 | 1 |
View Market Depth
| Last trade - 12.44pm 29/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |